메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

'김갑성' 기자의 전체기사

Positioning Da Nang as Southeast Asia's Leading Medica…

DA NANG, Vietnam, Oct. 3, 2025 -- Da Nang is set to host the Da Nang Global Business Summit 2025 under the theme "Unlocking the Future of Medical & Wellness Tourism: Innovation – Creativity – Global Connectivity". The two-day event will take place on November 11–12, 2025, at Fusion Resort & Villas Da Nang, affirming the city's ambition to become a leading hub for medical tourism in the region. The summit is expected to welcome over 200 senior leaders and policymakers from international hospitals, technology corporations, tourism enterprises, and government age
- 김갑성 기자
- 2025-10-03 17:37
Prudential Health Partnership Networking Cocktail Reception b…

Over 200 representatives from hospitals and medical institutions, together with doctors, gathered to celebrate their shared achievements HONG KONG, Oct. 3, 2025 -- Prudential Hong Kong Limited ("Prudential") hosted the Health Partnership Networking Cocktail Reception yesterday at the JW Marriott Hotel Hong Kong. The event welcomed over 200 distinguished guests, including HKSAR Executive Council Member Dr. Ko Wing-man, alongside doctors and representatives from hospitals and medical institutions across Chinese mainland, Hong Kong, and Macau. The reception served as a d
- 김갑성 기자
- 2025-10-03 17:29
スターラボ、合弁事業の戦略的パートナーおよび株式所有者としてスペース・アプリケー…

宇宙インフラ、ペイロード統合、ミッション運用における欧州のリーダー、スターラボに参画。ヒューストンおよびシドニー, 2025年10月3日 --Starlab Space LLCは本日、第76回国際宇宙会議において、ベルギーに拠点を置く宇宙工学およびペイロード統合のリーダー企業であるSpace Applications Servicesが、合弁事業パートナーおよび投資家として同社に加わったことを発表しました。このパートナーシップは、スターラボの世界的なフットプリントを拡大し、スターラボの顧客が利用できる機能を拡張する。 SpaceApps社は、航空電子工学、ペイロード開発、エンドツーエンドの国際商業実験キューブ（ICECubes）サービス、ミッション統合および運用管理ソフトウェアなどの機能を備え、宇宙システム、ミッション運用、ペイロード統合における深い経験に貢献している。同社はまた、欧州宇宙機関や国際的なパートナーとも緊密に協力し、スターラボの世界市場や研究コミュニティへのアクセスを広げている。「投資家として、またパートナーとしてSpaceAppsを加えることは、私たちがデザインから現実へと急速に移行していることを証明するものです」とスターラボCEOのマーシャル・スミスは語った。「国際的なパートナーからの
- 김갑성 기자
- 2025-10-03 16:32
Mediso installs true theranostic TheraMAX SPECT/CT at Heide…

HEIDELBERG, Germany, Oct. 3, 2025 -- Mediso completes the installation of an AnyScan® TRIO-TheraMAX SPECT/CT at the Department of Nuclear Medicine at Heidelberg University Hospital. The system is specifically designed for the clinical needs of theranostic imaging. Its detectors and collimators are developed for Targeted Radionuclide Therapies carried out with radioisotopes emitting alpha and beta particles and have co-emission of high and ultra-high energy gamma photons that are more challenging to image than diagnostic 99mTc. This requires maximized performance for
- 김갑성 기자
- 2025-10-03 16:12
Mediso installs true theranostic TheraMAX SPECT/CT at Heide…

HEIDELBERG, Germany, Oct. 3, 2025 -- Mediso completes the installation of an AnyScan® TRIO-TheraMAX SPECT/CT at the Department of Nuclear Medicine at Heidelberg University Hospital. The system is specifically designed for the clinical needs of theranostic imaging. Its detectors and collimators are developed for Targeted Radionuclide Therapies carried out with radioisotopes emitting alpha and beta particles and have co-emission of high and ultra-high energy gamma photons that are more challenging to image than diagnostic 99mTc. This requires maximized performance for
- 김갑성 기자
- 2025-10-03 15:39
Knee-d for excellence: New regional training hub keeps s…

SINGAPORE, Oct. 3, 2025 -- Singapore General Hospital (SGH) has announced the launch of a Centre of Excellence (CoE) for robotic-assisted surgery, ensuring orthopaedic surgeons are equipped with knowledge of emerging technologies as the population ages and surgical needs evolve. The Centre is established as part of a two-year strategic collaboration, formalised through a Memorandum of Understanding (MoU), with Johnson & Johnson MedTech with an initial focus on training and research in total knee replacement. Regional Training Hub for Southeast Asia The
- 김갑성 기자
- 2025-10-03 10:00
Nutromics unveils world-first real-time in vivo multiplexing data a…

MELBOURNE, Australia, Oct. 3, 2025 -- Diagnostics company Nutromics has presented the world's first real-time, continuous data on two critical antibiotics - vancomycin and tobramycin - measured simultaneously on the same device in animal models. The breakthrough was unveiled at the International Congress of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) in Singapore. The study, conducted in rats, demonstrated the Nutromics platform's ability to continuously track levels of multiple targets on the one device ('multiplexing'). Both vancomycin, among the most frequently dos
- 김갑성 기자
- 2025-10-03 08:48
MedHub-AI Announces National Reimbursement Approval in…

TEL AVIV, Israel, Oct. 3, 2025 -- MedHub-AI today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved national reimbursement for the company's AutocathFFR™ System, effective October 1, 2025. The decision follows regulatory approval by the Pharmaceuticals and Medical Devices Agency (PMDA) earlier this year and marks a significant milestone in expanding access to advanced coronary physiology assessment in Japan. The approval provides physicians and hospitals across Japan with broad access to AutocathFFR, the first fully automated, real-time AI-b
- 김갑성 기자
- 2025-10-03 07:00
스타랩, 전략적인 합작 투자 파트너로 스페이스 어플리케이션 서비스 영입

우주 인프라, 탑재체 통합 및 임무 관제 분야를 선도하는 유럽 기업이 국제적 역량을 강화하고 스타랩 고객에게 기술을 제공할 목적으로 스타랩에 합류 휴스턴 및 시드니, 2025년 10월 3일 -- 스타랩 스페이스 LLC(Starlab Space LLC)는 오늘 제76회 국제우주학회(International Astronautical Congress)에서 벨기에에 본사를 두고 우주 엔지니어링 및 탑재체 통합 분야를 선도하고 있는 스페이스 어플리케이션 서비스(Space Applications Services)가 합작 투자 파트너이자 투자자로 회사에 합류했다고 발표했다. 이번 파트너십으로 스타랩의 글로벌 영향력이 한층 더 강화되었을 뿐만 아니라 스타랩 고객에게 우수한 기술을 제공할 수 있게 되었다. 스페이스앱스(SpaceApps)는 다양한 기술을 통해 우주 시스템, 임무 관제 및 탑재체 통합에 대한 풍부한 경험을 함께 나누고 있다. 여기에는 항공 전자 시스템, 탑재체 개발, 포괄적인 국제 상업용 실험 큐브(ICECubes) 서비스, 임무 통합 및 관제 제어 소프트웨어 등이 있다. 또한 유럽우주국(European
- 김갑성 기자
- 2025-10-03 00:04
HKUST Scientists Reveal Critical Impacts of a Chinese Genetic…

HONG KONG, Oct. 2, 2025 -- A landmark study conducted by The Hong Kong University of Science and Technology (HKUST) has demonstrated that a genetic variant, TREM2 H157Y, significantly increases the risk of Alzheimer's disease (AD) in individuals of ethnic Chinese descent. The research reveals that this variant confers a risk level comparable to that of the strongest known genetic risk factor for AD, APOE-ε4, and is associated with more rapid clinical progression and more severe neurodegeneration. This is the first in the field to conduct an in-depth family-based clinical case study on
- 김갑성 기자
- 2025-10-02 22:42

이전

11 12 13 14 15 16 17 18 19 20

많이 본 기사

최근기사

2025-10-19_SUN

2025-10-18_SAT

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 10월 19일 15시 40분